Founded in 2005, Zhejiang Dongyun Pharmaceutical was located in the Hangzhou Bay Shangyu Economic and Technological Development Zone in Shangyu District, Shaoxing, Zhejiang Province, lying between the provincial capital of Hangzhou and the coastal city of Ningbo, in the hinterland of the Yangtze River Delta economic region. It is well-connected to the transport network, with two sea bridges leading straight to Shanghai, as well as easy access to an airport, the high-speed rail, expressways, national highways, canals and ports.
 

The company focuses on pharmaceutical manufacturing technology as its core, and develops and operates in the fields of pharmaceutical raw materials and animal health raw materials. It is dedicated to the research, production and operation of cephalosporin antibiotics. The company has the production capacity of 500 tons of sterile cephalosporin raw materials, 600 tons of oral cephalosporin raw materials, and 1,000 tons of pharmaceutical intermediates per year.

All the company's products have passed domestic GMP certification, and some have passed Korean MFDS certification. The leading products have obtained CEP certificates. The main products include cefuroxime sodium, cefuroxime ester, cefprozil, cefditox sodium, cefdiazine sodium, cefazolin sodium, ceftiazole sodium, ceftriaxone sodium, hydrochloric ceftriaxone, ceftriaxone, etc. The oral raw materials include cefprozil, etc. The pharmaceutical intermediates include ceftiazole acid, cefdiazine acid, cefditox acid, etc.